Skip to content

Feed Screener MCP Methodology

⌘K

EN

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
AMF · FR
BAFIN · DE

Product

Ask the record
Help
Methodology
Signal backtests
Terms
Privacy notice
Object to processing

Language

English Español Français

Feed Screener MCP Methodology

English Español Français

Pricing Sign in

Globeways Holdings Ltd — Radius Health, Inc. insider · InsiderLens

/ / Globeways Holdings Ltd

Globeways Holdings Ltd

10% owner at Radius Health, Inc. · on record since Feb 21, 2014
10% owner at CHIASMA, INC · on record since Jul 17, 2015
10% owner at TCR2 THERAPEUTICS INC. · on record since Feb 21, 2019
10% owner at Cullinan Therapeutics, Inc. · on record since Jan 14, 2021
Director at Kalaris Therapeutics, Inc. · on record since Aug 5, 2022
10% owner at Kalaris Therapeutics, Inc. · on record since Aug 5, 2022

Insider trading activity of Globeways Holdings Ltd

No transactions on record for Globeways Holdings Ltd.

Track record of Globeways Holdings Ltd

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Globeways Holdings Ltd

Co-insiders of Globeways Holdings Ltd

GADICKE ANSBERTCHIASMA, INC +4
Jovan-Embiricos MoranaCullinan Therapeutics, Inc. +3
EVNIN LUKECHIASMA, INC +2
F2 MG LtdCullinan Therapeutics, Inc. +2
F2 - TPO Investments LLCCullinan Therapeutics, Inc. +2
Foley ToddCHIASMA, INC +2
Allen Andrew RCullinan Therapeutics, Inc. +1
Baeuerle PatrickCullinan Therapeutics, Inc. +1
F2 MC, LLCCullinan Therapeutics, Inc. +1
Globeways Holdings II LtdKalaris Therapeutics, Inc. +1
Green JeremyKalaris Therapeutics, Inc. +1
Hughes OwenCullinan Therapeutics, Inc. +1
KAILIAN VAUGHN MCHIASMA, INC +1
MPM Bio IV NVS Strategic Fund LPCHIASMA, INC +1
MPM BioVentures IV GP LLCCHIASMA, INC +1
MPM BioVentures IV LLCCHIASMA, INC +1
MPM Oncology Impact Management GP LLCCullinan Therapeutics, Inc. +1
MPM Oncology Impact Management LPCullinan Therapeutics, Inc. +1
Oncology Impact Fund (Cayman) Management L.P.Cullinan Therapeutics, Inc. +1
Redmile Group, LLCKalaris Therapeutics, Inc. +1
Rosenberg AnthonyCullinan Therapeutics, Inc. +1
Scopa James PaulCHIASMA, INC +1
Tomasello ShawnKalaris Therapeutics, Inc. +1
UBS Oncology Impact Fund L.P.Cullinan Therapeutics, Inc. +1

This page republishes public regulatory disclosures.

Webster Stephen WCullinan Therapeutics, Inc. +1

7-MED Health Ventures LPCHIASMA, INC

Abingworth LLPCHIASMA, INC

ADAMIS ANTHONY PKalaris Therapeutics, Inc.

Adams Derek N.Kalaris Therapeutics, Inc.

Adler Lundgren Tamara L.Radius Health, Inc.

AHMED NADIMCullinan Therapeutics, Inc.

AKKARAJU SRINIVASKalaris Therapeutics, Inc.

Atillasoy ErcemKalaris Therapeutics, Inc.

AUERBACH ALAN HRadius Health, Inc.

Bayko Liisa AnnKalaris Therapeutics, Inc.

BB BIOTECH AGRadius Health, Inc.

BIOTECH GROWTH N VRadius Health, Inc.

BIOTECHNOLOGY VALUE FUND II LPCullinan Therapeutics, Inc.

BIOTECHNOLOGY VALUE FUND L PCullinan Therapeutics, Inc.

Biotechnology Value Trading Fund OS LPCullinan Therapeutics, Inc.

BIOTECH TARGET N VRadius Health, Inc.

Bornstein Jeffrey SKalaris Therapeutics, Inc.

Brainard DianaKalaris Therapeutics, Inc.

BRENNER LOUIS MDRadius Health, Inc.

Brenner MalcolmKalaris Therapeutics, Inc.

BROOKSIDE CAPITAL INVESTORS L PRadius Health, Inc.

BROOKSIDE CAPITAL MANAGEMENT LLCRadius Health, Inc.

BROOKSIDE CAPITAL PARTNERS FUND LPRadius Health, Inc.

BVF GP HOLDINGS LLCCullinan Therapeutics, Inc.

BVF I GP LLCCullinan Therapeutics, Inc.

Concerned by this data? Exercise your right to object →

No transactions on record. Reset filters